Skip to main navigation
  • Sustainability
  • Email Alerts
  • Contact Us
  • Language
    • English
    • 简体中文
    • 繁體中文
Zailab Logo Zailab Logo
  • Investor 
    Overview
  • Stock 
    Information
    • Stock Quote & Chart
    • Historical Lookup
    • Analyst Coverage
  • Corporate 
    Governance
    • Documents & Charters
    • Committee Composition
  • Events & 
    Presentations
    • Event Calendar
    • Webcasts & Presentations
    • Shareholder Meetings
  • Financials 
    & Filings
    • SEC Filings
    • HKEX Announcements & Notices
    • Annual Reports
  • Investor 
    Resources
    • Investor FAQ
    • Information Request
    • Investor & Media Contacts
  • News & 
    Media
    • Press Releases
    • Partner News
  • Search
  • Sustainability
  • Email Alerts
  • Contact Us
  • Language
    • English
    • 简体中文
    • 繁體中文

Press Release

General
Nov 23, 2015

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted.pdf 231 KB
Zai Lab Footer Logo
Copyright @ 2025 Zai Lab All Rights Reserved.
Contact Us
Top Main